William P Forbes
CIK 1314760 · EVP, Chief Development Officer · last filed 2026-11-03
William P Forbes is an EVP, Chief Development Officer who has filed 76 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for HRTX, was dated Nov 3, 2026. Across all open-market trades the lifetime net is −$16.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $93.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SLXP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
8510 COLONNADE CENTER DRIVE
RALEIGH, NC 27615
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRTX | EVP, Chief Development Officer | 252,366 | $0.37 | $93.5K | $74.2K | 26 | 2026-11-03 |
| XAIR | Director | 37 | $2.29 | $85 | $90.7K | 10 | 2025-11-06 |
| TRVI | Chief Development Officer | — | $15.31 | — | $0 | 4 | 2022-07-01 |
| SALIX PHARMACEUTICALS LTD (SLXP) Delisted | President, Medical R&D and CDO | 51,714 | — | — | -$16.55M | 35 | 2015-03-11 |
Recent Filings
76 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-11-03 | HRTX | Mixed | +16,789 | -$1.9K | EDGAR |
| 2026-10-21 | HRTX | Mixed | +2,772 | -$397 | EDGAR |
| 2026-08-03 | HRTX | Mixed | +16,789 | -$3.3K | EDGAR |
| 2026-07-20 | HRTX | Mixed | +2,773 | -$517 | EDGAR |
| 2026-06-08 | HRTX | Exer (M) | +12,500 | $0 | EDGAR |
| 2026-05-04 | HRTX | Exer (M) | +23,464 | $0 | EDGAR |
| 2026-04-21 | HRTX | Exer (M) | +3,874 | $0 | EDGAR |
| 2026-02-03 | HRTX | Grant (A) | — | $0 | EDGAR |
| 2026-02-03 | HRTX | Exer (M) | +11,695 | $0 | EDGAR |
| 2026-01-20 | HRTX | Exer (M) | +3,875 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.